We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

April 2, 2009

Genzyme Corporation v. Impax Laboratories, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. September 5, 2012

    Genzyme, Impax Bury Hatchet Over Kidney Disease Drugs

    Impax Laboratories Inc. on Tuesday settled patent infringement claims brought by Sanofi-Aventis SA subsidiary Genzyme Corp. over plans to make generic versions of two Genzyme kidney disease treatments, reaching a deal that will give Impax licensing rights in 2014.


To view the parties, register now.